Omalizumab for the Treatment of Multiple Food Allergies. Reply

N Engl J Med. 2024 May 30;390(20):1936. doi: 10.1056/NEJMc2404288.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adult
  • Anti-Allergic Agents* / therapeutic use
  • Antibodies, Anti-Idiotypic* / therapeutic use
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized* / therapeutic use
  • Food Hypersensitivity* / drug therapy
  • Humans
  • Immunoglobulin E / blood
  • Immunoglobulin E / immunology
  • Omalizumab* / therapeutic use

Substances

  • Anti-Allergic Agents
  • Antibodies, Anti-Idiotypic
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Immunoglobulin E
  • Omalizumab